Pediatric cardiomyopathy

The Australian experience

Robert G. Weintraub, Alan W. Nugent, Piers E F Daubeney

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Population-based studies have provided insight into the natural history of adult cardiomyopathy (CM), but comparable information for affected children is lacking. All Australian children diagnosed with primary CM at age 0-10 years between 1.1.1987 and 12.31.1996 were enrolled in a longitudinal cohort study. A single cardiologist and pathologist reviewed all cardiac investigations and histopathological material, respectively. During the study period, the overall incidence of CM was 1.24/105 person-years at risk. Indigenous children had a higher incidence of DCM (relative risk 2.8) and a higher rate of presenting death (16.7% vs. 2.6%). The 5-year freedom from death or transplantation was 63% for children with DCM (n = 184), 83% for those with HCM (n = 80), 53% for those with left ventricular non-compaction (LVNC) (n = 29) and 38% for those with RCM (n = 8). In subjects with DCM, positive viral identification and/or lymphocytic myocarditis were found in 30/44 (68.2%) cases with available early histology and 8/9 cases presenting with sudden death. Risk factors for death/transplantation comprised presenting age > 5 years, familial DCM, lower initial fractional shortening Z score and failure to increase fractional shortening Z score during follow-up. In subjects with HCM, an underlying syndromal, genetic or metabolic condition was identified in 46 (57.5%) of subjects. Risk factors for death/transplantation included concentric LV hypertrophy, presenting age < 1 year, lower initial fractional shortening Z score and increasing LV posterior wall Z score. Lymphocytic myocarditis and LVNC are important causes of childhood CM. This population-based study identifies pediatric subjects at risk of adverse events.

Original languageEnglish (US)
Pages (from-to)17-24
Number of pages8
JournalProgress in Pediatric Cardiology
Volume23
Issue number1-2
DOIs
StatePublished - Sep 2007

Fingerprint

Cardiomyopathies
Pediatrics
Transplantation
Myocarditis
Incidence
Sudden Death
Natural History
Hypertrophy
Population
Longitudinal Studies
Histology
Cohort Studies
Mortality

Keywords

  • Cardiomyopathy
  • Left ventricular non-compaction
  • Myocarditis
  • Sudden death
  • Transplantation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Pediatric cardiomyopathy : The Australian experience. / Weintraub, Robert G.; Nugent, Alan W.; Daubeney, Piers E F.

In: Progress in Pediatric Cardiology, Vol. 23, No. 1-2, 09.2007, p. 17-24.

Research output: Contribution to journalArticle

Weintraub, Robert G. ; Nugent, Alan W. ; Daubeney, Piers E F. / Pediatric cardiomyopathy : The Australian experience. In: Progress in Pediatric Cardiology. 2007 ; Vol. 23, No. 1-2. pp. 17-24.
@article{4e35816045bb4dbba585e70898dd2cf2,
title = "Pediatric cardiomyopathy: The Australian experience",
abstract = "Population-based studies have provided insight into the natural history of adult cardiomyopathy (CM), but comparable information for affected children is lacking. All Australian children diagnosed with primary CM at age 0-10 years between 1.1.1987 and 12.31.1996 were enrolled in a longitudinal cohort study. A single cardiologist and pathologist reviewed all cardiac investigations and histopathological material, respectively. During the study period, the overall incidence of CM was 1.24/105 person-years at risk. Indigenous children had a higher incidence of DCM (relative risk 2.8) and a higher rate of presenting death (16.7{\%} vs. 2.6{\%}). The 5-year freedom from death or transplantation was 63{\%} for children with DCM (n = 184), 83{\%} for those with HCM (n = 80), 53{\%} for those with left ventricular non-compaction (LVNC) (n = 29) and 38{\%} for those with RCM (n = 8). In subjects with DCM, positive viral identification and/or lymphocytic myocarditis were found in 30/44 (68.2{\%}) cases with available early histology and 8/9 cases presenting with sudden death. Risk factors for death/transplantation comprised presenting age > 5 years, familial DCM, lower initial fractional shortening Z score and failure to increase fractional shortening Z score during follow-up. In subjects with HCM, an underlying syndromal, genetic or metabolic condition was identified in 46 (57.5{\%}) of subjects. Risk factors for death/transplantation included concentric LV hypertrophy, presenting age < 1 year, lower initial fractional shortening Z score and increasing LV posterior wall Z score. Lymphocytic myocarditis and LVNC are important causes of childhood CM. This population-based study identifies pediatric subjects at risk of adverse events.",
keywords = "Cardiomyopathy, Left ventricular non-compaction, Myocarditis, Sudden death, Transplantation",
author = "Weintraub, {Robert G.} and Nugent, {Alan W.} and Daubeney, {Piers E F}",
year = "2007",
month = "9",
doi = "10.1016/j.ppedcard.2007.05.006",
language = "English (US)",
volume = "23",
pages = "17--24",
journal = "Progress in Pediatric Cardiology",
issn = "1058-9813",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Pediatric cardiomyopathy

T2 - The Australian experience

AU - Weintraub, Robert G.

AU - Nugent, Alan W.

AU - Daubeney, Piers E F

PY - 2007/9

Y1 - 2007/9

N2 - Population-based studies have provided insight into the natural history of adult cardiomyopathy (CM), but comparable information for affected children is lacking. All Australian children diagnosed with primary CM at age 0-10 years between 1.1.1987 and 12.31.1996 were enrolled in a longitudinal cohort study. A single cardiologist and pathologist reviewed all cardiac investigations and histopathological material, respectively. During the study period, the overall incidence of CM was 1.24/105 person-years at risk. Indigenous children had a higher incidence of DCM (relative risk 2.8) and a higher rate of presenting death (16.7% vs. 2.6%). The 5-year freedom from death or transplantation was 63% for children with DCM (n = 184), 83% for those with HCM (n = 80), 53% for those with left ventricular non-compaction (LVNC) (n = 29) and 38% for those with RCM (n = 8). In subjects with DCM, positive viral identification and/or lymphocytic myocarditis were found in 30/44 (68.2%) cases with available early histology and 8/9 cases presenting with sudden death. Risk factors for death/transplantation comprised presenting age > 5 years, familial DCM, lower initial fractional shortening Z score and failure to increase fractional shortening Z score during follow-up. In subjects with HCM, an underlying syndromal, genetic or metabolic condition was identified in 46 (57.5%) of subjects. Risk factors for death/transplantation included concentric LV hypertrophy, presenting age < 1 year, lower initial fractional shortening Z score and increasing LV posterior wall Z score. Lymphocytic myocarditis and LVNC are important causes of childhood CM. This population-based study identifies pediatric subjects at risk of adverse events.

AB - Population-based studies have provided insight into the natural history of adult cardiomyopathy (CM), but comparable information for affected children is lacking. All Australian children diagnosed with primary CM at age 0-10 years between 1.1.1987 and 12.31.1996 were enrolled in a longitudinal cohort study. A single cardiologist and pathologist reviewed all cardiac investigations and histopathological material, respectively. During the study period, the overall incidence of CM was 1.24/105 person-years at risk. Indigenous children had a higher incidence of DCM (relative risk 2.8) and a higher rate of presenting death (16.7% vs. 2.6%). The 5-year freedom from death or transplantation was 63% for children with DCM (n = 184), 83% for those with HCM (n = 80), 53% for those with left ventricular non-compaction (LVNC) (n = 29) and 38% for those with RCM (n = 8). In subjects with DCM, positive viral identification and/or lymphocytic myocarditis were found in 30/44 (68.2%) cases with available early histology and 8/9 cases presenting with sudden death. Risk factors for death/transplantation comprised presenting age > 5 years, familial DCM, lower initial fractional shortening Z score and failure to increase fractional shortening Z score during follow-up. In subjects with HCM, an underlying syndromal, genetic or metabolic condition was identified in 46 (57.5%) of subjects. Risk factors for death/transplantation included concentric LV hypertrophy, presenting age < 1 year, lower initial fractional shortening Z score and increasing LV posterior wall Z score. Lymphocytic myocarditis and LVNC are important causes of childhood CM. This population-based study identifies pediatric subjects at risk of adverse events.

KW - Cardiomyopathy

KW - Left ventricular non-compaction

KW - Myocarditis

KW - Sudden death

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=34547417531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547417531&partnerID=8YFLogxK

U2 - 10.1016/j.ppedcard.2007.05.006

DO - 10.1016/j.ppedcard.2007.05.006

M3 - Article

VL - 23

SP - 17

EP - 24

JO - Progress in Pediatric Cardiology

JF - Progress in Pediatric Cardiology

SN - 1058-9813

IS - 1-2

ER -